pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
grid-therapeutics PRESS RELEASE ARCHIVE
Nov 3, 2022
Grid Therapeutics Announces Upcoming Scientific Presentation at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
Jun 24, 2020
Grid Therapeutics Announces Enrollment of First Patient in Phase 1 Study of GT103 in Refractory NSCLC Patients
Apr 14, 2020
Grid Therapeutics Announces FDA Approval of IND Application for GT103
Apr 18, 2018
Grid Therapeutics Closes Series B Financing
Sep 14, 2017
Grid Therapeutics Closes Series A Financing
Aug 22, 2017
Grid Therapeutics Signs Exclusive License Agreement to Develop a Novel Immuno-Oncology Antibody
